XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.

$38.89  +1.96 (5.31%)
As of 12/02/2022 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  11/05/2014
Outstanding shares:  62,544,019
Average volume:  404,063
Market cap:   $2,309,750,622
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BRJ3GY4
Valuation   (See tab for details)
PE ratio:   -28.47
PB ratio:   3.62
PS ratio:   101.11
Return on equity:   -15.28%
Net income %:   -362.39%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy